Project Grant R01MH144153
Award Date 8/6/26
Completion Date 5/31/31
Dollars Obligated $641K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
St. Louis, MO 63110, USA
Similar Awards
- The National Institute of Neurological Disorders and Stroke awarded the University of North Carolina at Chapel Hill $615,286 on August 14, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to investigate the relationship between UBE3A mosaicism and Angelman syndrome phenotypic severity. The award funds research using complementary genetic approaches to evaluate how varying percentages of UBE3A-expressing and UBE3A-deficient neurons...
- Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $427,625 Project Grant to the University of Wisconsin–Madison (UW-Madison) effective June 1, 2025, through May 31, 2027, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). This project aims to identify cell-type-specific and developmental-stage-specific ubiquitinated proteins in UBE3A (ubiquitin protein ligase E3A) mutant mice to...
- The National Institute of Mental Health awarded The Washington University $763,894 on June 19, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate the role of the ZNF292 gene in cortical development and neurodevelopmental disorders. The research employs complementary experimental systems—mouse knockout models and human pluripotent stem cell-derived neurons carrying six pathogenic ZNF292 variants identified in patients with autism spectrum disorder, intellectual...
- The National Institute of Child Health and Human Development awarded The Ohio State University $426,914 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865, Assistance Listing 93.HDR) to investigate microRNA mechanisms in Angelman syndrome. The research targets dysregulated microRNA expression, specifically the mir-183/96/182 cluster identified as significantly downregulated in Angelman syndrome model mice. The study tests whether...
- The National Institute of Mental Health awarded The Washington University $735,920 on June 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate neural mechanisms of threat learning and avoidance behaviors. The research elucidates the temporal dynamics and causal roles of neurons in the supramammillary nucleus during threat learning, avoidance, and extinction using fiber photometry, optogenetics, and behavioral assays. The project determines whether these...
- The National Institute of Mental Health awarded The Washington University $147,268 on February 15, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate the function of autism spectrum disorder risk genes RFX3 and RFX4 during human cortical development. The research examines how pathogenic mutations in the genes encoding regulatory factor X3 and X4 transcription factors contribute to autism spectrum disorder and other neurodevelopmental disorders. The investigator...
- The National Institute of Mental Health awarded The Regents of the University of California, San Francisco (UCSF) $568,746 on August 11, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate the cellular mechanisms by which autism-associated protein SYNGAP1 functions at the primary cilium. The funded research tests the hypothesis that autism spectrum disorder risk genes play pleiotropic roles across subcellular compartments, including functionally significant roles...
- The National Institute of Mental Health awarded University of California, Los Angeles $764,785 under the Mental Health Research Grants program (CFDA 93.242) on July 16, 2026, to investigate context-dependent disease mechanisms in neurodevelopmental disorders, specifically the 16p11.2 chromosomal deletion (16PDEL) implicated in autism, intellectual disability, and ADHD. The project will use a proprietary in vitro human stem cell platform called the Cell Village to conduct high-throughput...
- The National Institute of Mental Health awarded The Washington University $110,595 on August 17, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate the feasibility of gene therapy for Tatton Brown Rahman Syndrome (TBRS), a rare neurodevelopmental disorder caused by mutations in DNMT3A. The project, led by an investigator identified as Kim, comprises two aims. Aim 1 employs spatial transcriptomics and single-nucleus RNA sequencing to assess how DNMT3A loss...
- The National Institute of Mental Health awarded Children's Research Institute $654,005 on June 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate the function of paralaminar amygdala neurons from adolescence to adulthood using a mouse model. The recipient will examine how paralaminar nucleus neuronal responses change over the adolescent-to-early-adulthood transition, determine the necessity and sufficiency of these neurons in that transition, and characterize...